Abstract:Biallelic ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) deficiency induces vascular/soft tissue calcifications in generalized arterial calcification of infancy (GACI), and low bone mass with phosphate-wasting rickets in GACI survivors (autosomal hypophosphatemic rickets type-2). ENPP1 haploinsufficiency induces early-onset osteoporosis and mild phosphate wasting in adults. Both conditions demonstrate the unusual combination of reduced accrual of skeletal mineral, yet excess and progressive heterotopic mineralization. ENPP1 is the only enzyme that generates extracellular pyrophosphate (PPi), a potent inhibitor of both bone and heterotopic mineralization. Life-threatening vascular calcification in ENPP1 deficiency is due to decreased plasma PPi; however, the mechanism by which osteopenia results is not apparent from an understanding of the enzyme's catalytic activity. To probe for catalysis-independent ENPP1 pathways regulating bone, we developed a murine model uncoupling ENPP1 protein signaling from ENPP1 catalysis, Enpp1T238A mice. In contrast to Enpp1asj mice, which lack ENPP1, Enpp1T238A mice have normal trabecular bone microarchitecture and favorable biomechanical properties. However, both models demonstrate low plasma Pi and PPi, increased fibroblast growth factor 23 (FGF23), and by 23 weeks, osteomalacia demonstrating equivalent phosphate wasting in both models. Reflecting findings in whole bone, calvarial cell cultures from Enpp1asj mice demonstrated markedly decreased calcification, elevated transcription of Sfrp1, and decreased nuclear β-catenin signaling compared to wild-type (WT) and Enpp1T238A cultures. Finally, the decreased calcification and nuclear β-catenin signaling observed in Enpp1asj cultures was restored to WT levels by knockout of Sfrp1. Collectively, our findings demonstrate that catalysis-independent ENPP1 signaling pathways regulate bone mass via the expression of soluble Wnt inhibitors such as secreted frizzled-related protein 1 (SFRP1), whereas catalysis dependent pathways regulate phosphate homeostasis through the regulation of plasma FGF23. © 2022 American Society for Bone and Mineral Research (ASBMR).

Increased Osteopontin Contributes To Inhibition Of Bone Mineralization In Fgf23-Deficient Mice

Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice.

Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice

Pth Ablation Ameliorates The Anomalies Of Fgf23-Deficient Mice By Suppressing The Elevated Vitamin D And Calcium Levels

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice

A G protein-coupled, IP3/protein kinase C pathway controlling the synthesis of phosphaturic hormone FGF23

Fgf-23/Klotho Signaling is Not Essential for the Phosphaturic and Anabolic Functions of Pth

Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization

Fibroblast growth factor 23-mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study

A Novel Distal Enhancer Mediates Inflammation-, PTH-, and Early Onset Murine Kidney Disease-Induced Expression of the Mouse Fgf23 Gene

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

Catalysis-Independent ENPP1 Protein Signaling Regulates Mammalian Bone Mass

Parathyroid Hormone 1 Receptor Is Essential To Induce Fgf23 Production And Maintain Systemic Mineral Ion Homeostasis

Reduced Osteoblastic Population and Defective Mineralization in Osteopetrotic (op/op) Mice

Oophorectomy‐induced Bone Loss is Attenuated in MAGP1‐deficient Mice

Mineralized Tissue Cells Are A Principal Source Of Fgf23

FGF23 Neutralization Improves Bone Quality and Osseointegration of Titanium Implants in Chronic Kidney Disease Mice

DNMT aberration-incurred GPX4 suppression prompts osteoblast ferroptosis and osteoporosis

Genetic Dissection of Phosphate- and Vitamin D-mediated Regulation of Circulating Fgf23 Concentrations.

Small molecule FGF23 inhibitors increase serum phosphate and improve skeletal abnormalities in Hyp mice